CHARLOTTE, N.C., Dec. 19, 2025 — cbdMD, Inc. (NYSE American: YCBD), a leading wellness firm and parent company of Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, announced today that it has entered into securities purchase agreements with institutional investors under which the Company issued an aggregate of 1,000,000 shares of Series C Convertible Preferred Stock in exchange for gross proceeds of $2.25 million to the Company. The Company plans to utilize the net proceeds of approximately $2.1 million for general corporate purposes and working capital to support its ongoing strategic initiatives. These Series C shares carry a 10% annual dividend and can be converted at the holder’s option into the Company’s common stock at an initial conversion price of $2.25 per share, subject to specific anti-dilution protections, with rights and preferences largely identical to the Company’s issued and outstanding Series B Convertible Preferred Stock.
“We are happy to keep bolstering our balance sheet to support the Company’s continuing efforts to broaden distribution of its consumer brands and to establish cbdMD for lasting profitability,” stated Ronan Kennedy, Chief Executive Officer and Chief Financial Officer of cbdMD.
This announcement does not represent an offer to sell or a solicitation of an offer to purchase any securities mentioned herein, nor will there be any sale of these securities in any state or jurisdiction where such offer, solicitation, or sale would be illegal before registration or qualification under the securities laws of that state or jurisdiction.
About cbdMD, Inc.
cbdMD, Inc. (NYSE American: YCBD) is a leading wellness firm that provides an extensive range of hemp-derived cannabinoid products made in the U.S., including CBD, CBG, CBN, and others. Its brand portfolio includes:
- Herbal Oasis – a hemp-derived THC social seltzer that is transforming how people socialize, relax, and celebrate life.
- ATRx Labs – functional mushroom supplements that promote focus, tranquility, and vitality.
- Paw CBD – among the most well-known CBD brands for pets.
The Company is dedicated to quality, innovation, and transparency, offering products through online channels and retail partners throughout the United States. For more information about cbdMD and its full range of U.S.-grown hemp products and other brands, please visit , , or, follow cbdMD on Instagram and Facebook, or stop by any of the thousands of retail locations that stock cbdMD products.
Forward-Looking Statements
This announcement includes certain forward-looking statements based on current expectations that entail risks and uncertainties under the U.S. Private Securities Litigation Reform Act of 1995, including remarks concerning profitability and compliance with listing requirements. These forward-looking statements may be identified by words such as ”should,” ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”projects,” ”forecasts,” ”expects,” ”plans,” and ”proposes.” These forward-looking statements do not guarantee future performance and are subject to risks, uncertainties, and other elements, some beyond our control and hard to foresee. You should thoroughly review and consider all cautionary statements, including but not limited to expectations regarding our ability to continue as a going concern, revenue growth, and other disclosures, particularly those under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2024, filed with the Securities and Exchange Commission (the “SEC”) on December 17, 2024, and our other SEC filings. All forward-looking statements involve substantial risks and uncertainties that could cause actual results to vary significantly from those projected in the statements, many of which are generally beyond cbdMD, Inc.’s control and difficult to anticipate. cbdMD, Inc. assumes no obligation to update any forward-looking statements except as required by law. Information appearing on our websites and social media platforms, including but not limited to Instagram and Facebook, is not included in this announcement.
Contact Information:
cbdMD, Inc.
Ronan Kennedy
Chief Executive Officer and Chief Financial Officer
(704) 445-3064
SOURCE cbdMD, Inc.